46 results found.
Enabling Technology and Integrated Selling Strategies Drove Orthopedic Growth in the Third Quarter
The third quarter of 2019 brought some standout performances from large players like Stryker, Medtronic, NuVasive and Globus Medical. DePuy Synthes and Zimmer Biomet made incremental progress in returning to market growth. Notably, the top performing players all have well-established enabling tec...
Medicrea Growth Driven by U.S. Sales of Patient-Specific Implants
Medicrea reports 3Q19 revenue of €8.2MM (USD $9.2MM), +12.3% vs. 3Q18.
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
By Mike Evers The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies listed herein had combined total orthopedic sales of $8....
Medicrea Reports 1Q19 Revenue of €7.7MM, +10.6% vs. 1Q18
Medicrea reports 1Q19 revenue of €7.7MM (USD $9.5MM), +10.6% vs. 1Q18.
Revenue Review: 4Q18 and Full Year 2018 Performance Highlights for Public Companies
By Mike Evers Below you’ll find a summary of the major 4Q18 and full year 2018 developments for publicly-traded orthopedic companies. Exhibits 1 and 2 show 4Q18 and full year performance, respectively.  Companies continue to refine their strategies to improve sales mix ...
Medicrea Reports 4Q18 Revenue of €8MM, +33.3% vs. 4Q17
Medicrea reports 4Q18 revenue of €8MM (USD $9.9MM), +33.3% vs. 4Q17, with 2018 revenue o...
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
Medicrea Reports 3Q18 Revenue of €7.3MM, +14.1% vs. 3Q17
Medicrea reports 3Q18 revenue of €7.3MM (USD $9.0MM), +14.1% vs. 3Q17.
Public and Private Company Revenue Review: 1Q17
By Julie A. Vetalice We're eager to see 2Q17 results to prepare a 1H review for you. In the interim, here are the 1Q17 numbers for publicly-traded companies, with updates and estimates for a number of privately-traded companies, too. Exhibits 1 and 2 illustrate 1Q17 performanc...
Medicrea 1Q17 Revenue
Medicrea posted 1Q17 revenue of €7.0MM (~US $7.5MM), -6.3% vs. 1Q16. 
Company Revenue 3Q16: A Final Look
By Julie A. Vetalice As we wrap up orthopaedic revenue for the latest reporting period, we observe that Stryker and Zimmer Biomet lead the largest orthopaedic companies in 3Q16 growth:
Medicrea Posts 3Q16 Revenue
Medicrea posted 3Q16 revenue of €6.8MM (~US $7.6MM), -4.3% vs. 3Q15. 
Company Revenue Update, 1H16
By Julie A. Vetalice We complete our coverage of 1H16 revenue in this issue. Stryker and Smith & Nephew lead the top five in growth, with 1H16 performance in the low-single-digits compared to 1H15. DePuy Synthes and Zimmer Biomet reported
Medicrea Reports 2Q16 Revenue
Medicrea posted 2Q16 revenue of €7.8MM (~US $8.7MM), -2.5% vs. 2Q15 as-reported.
Medicrea Posts 1Q16 Revenue
Medicrea posted 1Q16 revenue of €7MM (~US $7.9MM), +20% vs. 1Q15. (U.S. +27%, France +20%)
Medicrea Posts 2015 Revenue
Medicrea posted 2015 revenue of €27.8MM (~US $30.2MM), +15% vs. 2014.
Company Revenue 2015: Medicrea
Download the March issue of ORTHOKNOW for a graphical presentation of 2015 company performance. 2015: €27.8MM (~US $30.3M...
Medicrea Reports 3Q15 Revenue +12%
Medicrea posted 3Q15 revenue of €7.1MM (~US $8MM), +12% from 3Q14. 
BARE BONES® - July 9, 2015
Medicrea posted 1H15 sales of €13.8MM (~US $15.2MM), +16% vs. 1H14. (Medicrea, 7/9/15)
BARE BONES® - January 16, 2015
Medicrea posted 2014 revenue of €24.2MM (~US $28.49MM), +6% from 2013. (Medicrea International SA, 1/1...
2014 Revenue: Medicrea
€24.2MM (~US $28.49MM), +6% In 1H14, sales growth in American and French markets offset by temporary import issues in Brazil In 2H14, growth supported by U.S. development and effects of new international sales teams U.S. (the group's prior...
BARE BONES® - July 11, 2014
Medicrea posted 1H14 sales of €11.9MM (~US $16.2MM), flat vs. 1H13. (U.S. ~$9MM, +13%; ex-U.S. ~$7.1MM, -13%) (
2Q14 Revenue: Medicrea
 (1H14 sales) €11.9MM (~US $16MM), flat U.S. ~$9MM, +13% France ~$2.6MM, +36% Europe ~$2.8MM, -2% South America ~$1.0MM, -53% Asia ~$0.5MM, -35%   Growth in ...
BARE BONES® - April 11, 2014
Medicrea posted 1Q14 sales of €5.4MM (~US $7.5MM), flat compared to 1Q13. (France +40%, U.S. subsidiary +18%) (
1Q14 Revenue: Medicrea
€5.4MM (~US $7.5MM), flat (France +40%, U.S. subsidiary +18%) Growth affected by import difficulties with distribution in Brazil (since resolved)  
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2020 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group